Although iPLA2 VIA can regulate peripheral glucose-stimulated insulin secretion, apoptosis and mitochondrial fatty acid oxidation [45,46], its involvement in modulating brain lipid metabolism in the metabolic syndrome is not known [38]. This evidence concerns the gene PLA2G6 and metabolic syndrome.